title: [Use of cabergoline for prevention of ovarian hyperstimulation syndrome in assisted reproductive technologies].
abstract: Presentation of seven cases of patients at risk for moderate or severe OHSS, treated with Cabergoline.
authors.forename: G
authors.initials: G
authors.lastname: Kozovski
authors.forename: M
authors.initials: M
authors.lastname: Angelova
authors.forename: P
authors.initials: P
authors.lastname: Kacarova
mesh_terms: D000077465:Cabergoline; D018491:Dopamine Agonists / Q000627:therapeutic use*; D004873:Ergolines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016471:Ovarian Hyperstimulation Syndrome / Q000209:etiology* / Q000473:pathology / Q000517:prevention & control*; D010053:Ovary / Q000187:drug effects / Q000473:pathology; D010062:Ovulation Induction / Q000009:adverse effects*; D011247:Pregnancy
chemical_list: D018491:Dopamine Agonists; D004873:Ergolines; D000077465:Cabergoline